These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4904999)

  • 1. [A.I.C.A. orotate in hepatic pathology].
    Monges H; Salducci J
    Therapeutique; 1969 Nov; 45(9):911-2. PubMed ID: 4904999
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aicamine in hepatic pathology].
    Cachin M; Pergola F
    Rev Med Chir Mal Foie; 1971; 46(6):263-4. PubMed ID: 5151972
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical trials of Aicamin].
    Azzena D; Trasciatti S; Capuzzo R
    Minerva Dietol Gastroenterol; 1977; 23(4):345-51. PubMed ID: 349423
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experimentation with Aïcamine in hepatic insufficiency].
    Négret JP
    Bord Med; 1972 Apr; 5(8):973-6. PubMed ID: 5053280
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current views on the liver-protective therapy: clinical evaluation of 4-amino-5-carbamide imidazole 2,4-dihydroxy-6-pyrimidine carbonate].
    Tàmmaro AE; Bonaccorso O
    Clin Ter; 1975 Oct; 75(2):141-51. PubMed ID: 1227763
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical study of AICA orotate in hepatitis and cirrhosis].
    Chanoine F
    Acta Gastroenterol Belg; 1969; 32(4-5):383-95. PubMed ID: 4927897
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical studies on the liver-protective effect of 4-amino-5-imidazole carboxamide and orotic acid].
    Fehér VJ; Jakab L; Tenczer J; Szilvási I
    Dtsch Z Verdau Stoffwechselkr; 1977; 37(4):175-9. PubMed ID: 75788
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the diagnosis and therapy of chronic hepatopathies. Experiences with Orgatract].
    Bogenhard H
    Ther Ggw; 1965 Jun; 104(6):841-53. PubMed ID: 5318048
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experience with the oral liver-therapeutic agent Hepavis].
    Bayazid A; Gerhard W
    Med Welt; 1976 Nov; 27(46):2248-9. PubMed ID: 794616
    [No Abstract]   [Full Text] [Related]  

  • 10. [Controlled clinical evaluation of the therapeutic effectiveness of AICA orotate in chronic hepatitis].
    Roda E; Sama C; Festi D
    Clin Ter; 1979 Jun; 89(5):489-93. PubMed ID: 535326
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic activity of 2,4-dihydroxy-6-pyrimidine carbonate of 4-amino-5-carbamide-imidazole].
    Pasotti C
    Clin Ter; 1975 Nov; 75(3):281-9. PubMed ID: 776509
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of hepato-biliary diseases in children and adults by a drug composed of orotic acid and sorbitol].
    Cachin M; Alagille D
    Presse Med (1893); 1967 Apr; 75(17):859-60. PubMed ID: 6021371
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic testing of a mixture of orotic acid and sorbitol in adults with hepato-biliary diseases].
    Girard MM
    J Med Lyon; 1967 Sep; 48(127):1269-70. PubMed ID: 5619472
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of nucleic acid precursors on liver injuries. II. The influences of AICA and AICA orotate on metabolisms in liver injuries and their clinical significances.
    Hashimoto S
    J Vitaminol (Kyoto); 1967 Mar; 13(1):19-25. PubMed ID: 6059490
    [No Abstract]   [Full Text] [Related]  

  • 15. [First experience with potassium orotate therapy of chronic liver diseases].
    DOTTI F; BONETTI G
    Riforma Med; 1958 Jun; 72(24):666-72. PubMed ID: 13579934
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled clinical trial of 5(4)-amino-4(5)-imidazole carboxyamide ureidosuccinate, a new hepatic therapeutic agent stimulating liver regeneration and protein anabolism].
    Busin S; Micheli PL; Sovera A
    Clin Ter; 1977 Dec; 83(5):483-529. PubMed ID: 343971
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical applications of lithium orotate. A two years study.
    Nieper HA
    Agressologie; 1973; 14(6):407-11. PubMed ID: 4607169
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reflections on medicamentous liver-therapy. Hepavis in medical practice].
    Wegener W
    Med Monatsschr; 1977 Jul; 31(7):328-30. PubMed ID: 904570
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of 5(4) amino 4(5) imidazolcarboxamide ureidosuccinate in inflammatory and degenerative liver].
    Bianchi PG; Saccabusi E
    Minerva Gastroenterol; 1972; 18(4):245-56. PubMed ID: 4614121
    [No Abstract]   [Full Text] [Related]  

  • 20. [Metabolic effects of orotic acid].
    Müller G
    Z Gesamte Inn Med; 1984 Jun; 39(12):269-73. PubMed ID: 6485418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.